November 9, 2021
Eli Lilly Japan and Torii Pharmaceutical said on November 8 that they will end their marketing collaboration in Japan for the psoriasis drug Taltz (ixekizumab) upon the termination of their current agreement at the end of December. An anti-human IL-17A...read more